All reports
All KCE reports are available in Dutch, French and English under several formats. Form and language of the reports
- (-) Remove Health technology assessment filter Health technology assessment (15)
- Biological and genetic diagnostic tests (3) Apply Biological and genetic diagnostic tests filter
- (-) Remove Cancer filter Cancer (15)
- Digestive System Diseases (1) Apply Digestive System Diseases filter
- Drugs (1) Apply Drugs filter
- Gynaecology, pregnancy and delivery (3) Apply Gynaecology, pregnancy and delivery filter
- Medical imaging (1) Apply Medical imaging filter
- Pediatrics (1) Apply Pediatrics filter
- Prevention, Screening and vaccination (4) Apply Prevention, Screening and vaccination filter
- Urology and kidneys (2) Apply Urology and kidneys filter
-
[Hadrontherapy]
KCE Reports 67 (2007)
-
[Prostate-specific-antigen (PSA) for the screening of prostate cancer]
KCE Reports 31 (2006)
-
[Rapid assessment of a selection of new treatments for prostate cancer and benign prostate hypertrophy]
KCE Reports 89 (2008)
-
[Screening for Colorectal Cancer : current evidence and budget impact for Belgium.]
KCE Reports 45 (2006)
-
Autologous breast reconstruction techniques after mammary resection: time measurements for a potential reevaluation of the surgeon fee
KCE Reports 251 (2015)
-
Bevacizumab in the treatment of ovarian cancer
KCE Reports 285 (2017)
-
Cervical cancer screening program and Human Papillomavirus (HPV) testing, part II: Update on HPV primary screening
KCE Reports 238 (2015)
-
Gene expression profiling and immunohistochemistry tests for personalised management of adjuvant chemotherapy decisions in early breast cancer – a Rapid Assessment
KCE Reports 237 (2015)
-
Hadron therapy in children – an update of the scientific evidence for 15 paediatric cancers
KCE Reports 235 (2015)
-
HPV Vaccination for the Prevention of Cervical Cancer in Belgium: Health Technology Assessment
KCE Reports 64 (2007)
-
Innovative radiotherapy techniques: a multicentre time-driven activity-based costing study
KCE Reports 198 (2013)
-
MammaPrint® test for personalised management of adjuvant chemotherapy decisions in early breast cancer
KCE Report 298 (2018) Breast cancer is the most commonly diagnosed cancer in women in Belgium and throughout the world. Provided this cancer is in the early stage, treatment is essentially locoregional, that is, via surgery alone or combined with radiation therapy. In theory, this treatment is enough to eradicate the tumour since it is still limited. However, it is known that about 30% of patients treated in this way are at risk of developing remote metastases, because metastatic cancerous cells are already present but undetectable at the time of diagnosis.
-
Next generation sequencing gene panels for targeted therapy in oncology and haemato-oncology
KCE Reports 240 (2015)
-
Proton beam therapy in adults
KCE Reports 307 (2019) Proton therapy is a radiation therapy technique which allows large doses of radiation to be delivered to cancerous tumours without (excessively) “overflowing” to adjacent tissues. There has been much talk of this technique in recent years, since two projects by proton therapy centres are ongoing in Belgium, one in Louvain and the other in Charleroi.
-
Trastuzumab in Early Stage Breast Cancer
KCE Reports 34 (2006) 30 June (2nd edition; 22 June 2006, 1st edition)